2 results match your criteria: "and University Clinic Giessen and Marburg[Affiliation]"
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.
PLoS One
January 2016
Department of Hematology, Oncology and Immunology, Philipps University of Marburg, and University Clinic Giessen and Marburg, Marburg, Germany.
RAS mutations are frequently found among acute myeloid leukemia patients (AML), generating a constitutively active signaling protein changing cellular proliferation, differentiation and apoptosis. We have previously shown that treatment of AML patients with high-dose cytarabine is preferentially beneficial for those harboring oncogenic RAS. On the basis of a murine AML cell culture model, we ascribed this effect to a RAS-driven, p53-dependent induction of differentiation.
View Article and Find Full Text PDFClinical management of massive retroperitoneal hemorrhage after bone marrow biopsy.
Leuk Lymphoma
March 2009
Department of Gastroenterology, Endocrinology and Metabolism, Philipps University Marburg and University Clinic Giessen and Marburg, Marburg, Germany.